Search results
6 types of foods and drinks to avoid when taking Ozempic or Wegovy for weight loss
TODAY via Yahoo News· 2 days agoWeight loss is a famous side effect of Ozempic, the Type 2 diabetes drug, but patients often find...
Study: Ozempic boosts health, survival of patients with kidney disease, Type 2 diabetes
United Press International via Yahoo News· 6 hours agoFile Photo by Ida Marie Odgaard/EPA-EFE Ozempic provides a wide variety of health benefits for...
US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients
Reuters via AOL· 5 hours agoNovo is aiming to be the first to hit the market with a weekly insulin product, offering an...
A man who reversed his type 2 diabetes shares his high-fiber, high-protein pancake recipe
INSIDER via Yahoo News· 8 hours agoHe tops them with sugar-free syrup and butter. OatmealStories/Getty Images A CEO in his 60s has used...
Type 2 diabetes: £1m funding for heart treatment research
BBC News· 17 hours agoA £1m grant has been given to a university to support research into type 2 diabetes. The British...
Ozempic reduces risk of serious illness and death in people withdiabetes and kidney disease, study...
CNN via Yahoo News· 15 hours agoWeekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious...
Weight-loss drugs reduce kidney complication risks: Study
The Hill via Yahoo News· 9 hours agoThe active ingredient in Ozempic and Wegovy may help reduce the risk of kidney failure in those with...
FDA advisers weigh benefits of weekly insulin for people with diabetes
CNN via AOL· 5 hours agoMost types of insulin therapy, an important part of diabetes treatment for many people, are given as...
Type 2 diabetes treatment found to impact fungal community in human gut
Medical Xpress· 9 hours ago"This work highlights for the first time that metformin can confound associations of gut fungi with...
Semaglutide significantly reduces risk of complications in patients with type 2 diabetes, study...
Medical Xpress· 10 hours agoA pioneering study has demonstrated that semaglutide significantly reduces the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in patients with